🚀 New: PharmaLCA officially launched at CPHI Milan. Start for free →
From a published standard to PharmaLCA
01
Pharma LCA Consortium
Twelve leading pharmaceutical companies join forces to shape a common standard.
02
PAS 2090
The first harmonised methodology for pharmaceutical product LCAs, published by BSI at the end of 2025.
03
AllocNow selected
Chosen through a competitive tender by the Pharma LCA Consortium to build the software.
04
PharmaLCA launched
Built by AllocNow in collaboration with the Pharma LCA Consortium. Released at CPHI Milan in October 2026.
A new standard for pharmaceutical LCAs
Life Cycle Assessments (LCAs) are essential for understanding and improving the environmental performance of pharmaceutical products. Yet robust and comparable assessments have traditionally been difficult to conduct.
PAS 2090 changes that. It provides the first harmonised methodology for measuring and communicating the environmental impacts of pharmaceutical products.
Stakeholders involved
475+
Countries represented
35
PAS 2090 published
2025
PHARMA LCA CONSORTIUM
AstraZeneca
Chiesi
GSK
Johnson & Johnson
Merck KGaA
MSD
Novartis
Novo Nordisk
Pfizer
Roche
Sanofi
Takeda Pharmaceuticals
Why AllocNow
Deep LCA expertise
10M+ product carbon footprint and life-cycle assessment calculations performed
Proven in industry
Trusted by leading chemical, pharmaceutical and process industry companies
Purpose-built LCA
Combining deep LCA expertise with state-of-the-art software and data engineering
Building PharmaLCA
Nov 2025
PAS 2090 publication
Shaped by more than 475 stakeholders across 35 countries. Published by BSI at
the end of 2025.
Dec 2025
AllocNow selection and kick-off
Following AllocNow's selection, AllocNow and the Pharma LCA Consortium begin developing PharmaLCA.
May 2026
MVP and external testing
After six months of development and testing, the MVP of PharmaLCA is unveiled at the Pharma Sustainability Days in Geneva.
Oct 2026
Launch at CPHI Milan
The Pharma LCA Consortium and AllocNow officially launch PharmaLCA at CPHI Milan, bringing PAS 2090 to life in software.
The result: PharmaLCA
Looking ahead
PharmaLCA is more than software. It represents a shared commitment to improving environmental transparency across the pharmaceutical value chain.
​
The launch of PharmaLCA in October 2026 is only the beginning. We will continue to develop PharmaLCA alongside PAS 2090, its users, and the industry it serves.